Change of Company Name

RNS Number : 1112X
Roquefort Investments PLC
31 December 2021
 

 

31 December 2021

 

Roquefort Therapeutics plc

("Roquefort Therapeutics" or the "Company")

 

Change of Company Name

 

Roquefort Therapeutics (LSE:ROQ), the London listed investment company established to acquire businesses focused on early-stage opportunities in the biotechnology sector , is pleased to announce that the company name of Roquefort Investments plc has changed to Roquefort Therapeutics plc. The  Company's ordinary shares will continue to trade under the ticker ROQ, ISIN GB00BMDQ2T15 and SEDOL code BMDQ2T1.  

 

No action from shareholders is required in relation to the change.

 

Enquiries:

Roquefort Therapeutics plc

Stephen West (Chairman)

+44 (0)20 3290 9339

 

Buchanan (Public Relations)

Ben Romney / Jamie Hooper / George Beale

 

Optiva Securities Limited (Broker)

 

+44 (0)20 7466 5000

roq@buchanan.uk.com

 

Christian Dennis

+44 (0)20 3411 1881

 

For further information, please visit www.roquefortinvest.com and @roquefortinvest on Twitter.

 

LEI: ‎254900P4SISIWOR9RH34

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CANDKKBNFBDDQBN
UK 100

Latest directors dealings